Aurolab
15
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
67%
10 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Safety and Surgical Performance Study of Aurosleek Surgical Blades
Role: lead
Clinical Evaluation of Toric Intraocular Lens Made by Aurolab
Role: lead
Safety and Efficacy Study of Artificial Cornea
Role: lead
Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma
Role: lead
Clinical Evaluation of a New Cartridge for the Implantation of Foldable Intraocular Lenses
Role: lead
Natural History of IOL in Pseudo Exfoliation Syndrome
Role: lead
Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP
Role: lead
Efficacy of Aurosling in Frontalis Sling Suspension Surgery
Role: lead
Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost
Role: lead
Posterior Capsule Opacification Study
Role: lead
The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction
Role: lead
The Safety and Efficacy of Lacrimal Silicone Intubation for the Management of Epiphora
Role: lead
Study of PGA Suture in Ophthalmology
Role: lead
Aurolab Hydrophobic Foldable Intraocular Lens Study
Role: lead
Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy
Role: lead
All 15 trials loaded